We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAND
1926
DELISTED
Sandstorm Gold
SAND
$1.14M ﹤0.01%
+197,440
New +$1.36M
RTX icon
1927
PUT
RTX Corp
RTX
$295B
$1.13M ﹤0.01%
13,200
+4,700
+55% +$402K
PVLA
1928
Palvella Therapeutics
PVLA
$2.05B
$1.13M ﹤0.01%
2,743
+2,488
+976% +$866K
CASI
1929
DELISTED
CASI Pharmaceuticals
CASI
$1.13M ﹤0.01%
95,204
+72,833
+326% +$985K
RKLY.WS
1930
CALL
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$1.13M ﹤0.01%
+150,000
New +$336K
SMCI icon
1931
Super Micro Computer
SMCI
$18.4B
$1.13M ﹤0.01%
+308,720
New +$1.12M
ONEW icon
1932
OneWater Marine
ONEW
$217M
$1.13M ﹤0.01%
28,078
-60,219
-68% -$2.53M
MIDD icon
1933
Middleby
MIDD
$6.11B
$1.13M ﹤0.01%
6,600
-4,858
-42% -$878K
UA icon
1934
Under Armour Class C
UA
$2.97B
$1.12M ﹤0.01%
63,997
-435,588
-87% -$8.34M
PGNY icon
1935
Progyny
PGNY
$2.41B
$1.12M ﹤0.01%
19,937
-862
-4% -$47.6K
IEP icon
1936
Icahn Enterprises
IEP
$5.26B
$1.11M ﹤0.01%
22,320
-2,749
-11% -$152K
SVFB
1937
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$1.11M ﹤0.01%
+113,580
New +$1.12M
UPS icon
1938
United Parcel Service
UPS
$89.7B
$1.11M ﹤0.01%
6,099
-218,364
-97% -$43.1M
HBMD
1939
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$1.11M ﹤0.01%
+54,831
New +$1.05M
WYNN icon
1940
CALL
Wynn Resorts
WYNN
$10.3B
$1.11M ﹤0.01%
+13,100
New +$1.29M
OMP
1941
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$1.11M ﹤0.01%
49,577
+32,778
+195% +$717K
AFMD
1942
DELISTED
Affimed
AFMD
$1.1M ﹤0.01%
+17,849
New +$1.17M
BNY
1943
Bank of New York Mellon
BNY
$106B
$1.1M ﹤0.01%
+21,247
New +$1.1M
VRN
1944
DELISTED
Veren
VRN
$1.1M ﹤0.01%
+238,905
New +$883K
EW icon
1945
Edwards Lifesciences
EW
$48.2B
$1.1M ﹤0.01%
9,711
-17,904
-65% -$2.04M
PCB icon
1946
PCB Bancorp
PCB
$396M
$1.1M ﹤0.01%
55,039
+2,529
+5% +$47.4K
VZ icon
1947
PUT
Verizon
VZ
$201B
$1.1M ﹤0.01%
+20,300
New +$1.12M
LIDRW icon
1948
CALL
AEye Inc Warrant
LIDRW
$323K
$1.09M ﹤0.01%
200,000
CNVY
1949
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$1.09M ﹤0.01%
130,252
-64,515
-33% -$574K
NOVA
1950
DELISTED
Sunnova Energy
NOVA
$1.09M ﹤0.01%
33,175
-40,260
-55% -$1.42M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.